What systemic treatment do you utilize for patients with metastatic fibrosarcomatous DFSP that have progressed on imatinib?
Would you prefer doxorubicin based chemotherapy or are alternative TKIs useful in this scenario?
1 Answer
Mednet MemberInvited Expert
Medical Oncology · University of Texas MD Anderson Cancer Center
Answered on
Unfortunately, these fibrosarcomas do not respond well to other TKIs. Modest activity of standard STS chemotherapy.
Join for free or sign in to see the full answer